Solarvest BioEnergy Inc.

Equities

SVS.H

CA83416D1050

Environmental Services & Equipment

Market Closed - Toronto S.E. 09:55:33 2023-09-05 am EDT 5-day change 1st Jan Change
0.025 CAD -.--% Intraday chart for Solarvest BioEnergy Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Solarvest BioEnergy Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
Solarvest BioEnergy Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023 CI
Solarvest BioEnergy Inc. Announces Board Changes CI
Solarvest BioEnergy Inc. Reports Earnings Results for the Full Year Ended July 31, 2023 CI
Solarvest BioEnergy Inc. Says Michael Farley Appointed as President, Effective Immediately; Adds Claes Ellegaard Agreed to Tender His Resignation MT
Solarvest BioEnergy Inc. Brief: Michael Farley Appointed as President, Effective Immediately; Says Claes Ellegaard Agreed to Tender His Resignation MT
Solarvest BioEnergy Inc. Announces Management Changes CI
Solarvest BioEnergy Inc. Announces Board Changes CI
Solarvest BioEnergy Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
Solarvest BioEnergy Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
Solarvest BioEnergy Inc. announced that it has received CAD 0.5419 million in funding CI
Solarvest BioEnergy Inc. Appoints Leslie Auld as Chief Financial Officer CI
Solarvest Bioenergy Inc. Announces That It Has Been Granted A Patent for Organic Omega-3 in Brazil CI
Solarvest BioEnergy Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
Solarvest BioEnergy Inc. Reports Earnings Results for the Full Year Ended July 31, 2022 CI
Solarvest BioEnergy Inc. Auditor Raises 'Going Concern' Doubt CI
Solarvest BioEnergy Inc. Announces Board Changes CI
Solarvest BioEnergy Inc. announced that it expects to receive CAD 0.65 million in funding CI
Solarvest BioEnergy Inc. Appoints Claes Ellegaard as Chief Executive Officer CI
Solarvest Bioenergy Inc. Adds Two People to the Advisory Board CI
Solarvest Bioenergy Inc. Announces that Richard Groome Agrees to Chair its Newly Created Financial Advisory Committee and to Support the Recruitment of Two Additional Members CI
Solarvest BioEnergy Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022 CI
Solarvest BioEnergy Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022 CI
Solarvest Bioenergy Inc. Receives Organic Omega-3 Patent in Japan CI
Solarvest BioEnergy Inc. Reports Earnings Results for the First Quarter Ended October 31, 2021 CI
Chart Solarvest BioEnergy Inc.
More charts
Solarvest BioEnergy Inc. is a Canada-based algae biologics company. The Company’s production platform provides it with a flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. It has developed and patented Omega-3, which is ocean-based (Docosahexaenoic Acid (DHA) & Eicosapentaenoic Acid (EPA)) and organic. The products are produced without chemicals, solvents, and/or heavy processing that degrade the nutritional benefits. It offers a plant-based and sustainable product while avoiding ocean-based toxins/pollutants or residual processing solvents. Its project focuses on cannabinoids, which implements a research and development program to produce cannabidiol (CBD), cannabigerol (CBG) and tetrahydrocannabinol (THC). It has also produced Bone Morphogenetic Protein (BMP) in micro algae. Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. SVS.H Stock
  4. News Solarvest BioEnergy Inc.
  5. Solarvest BioEnergy Inc. Brief: Michael Farley Appointed as President, Effective Immediately; Says Claes Ellegaard Agreed to Tender His Resignation